Search

Frank M Kochinke

from San Jose, CA
Age ~68
Get Report
Also known as:
Frank M Kockinke
Phone and address:
3413 Antonacci Ct, San Jose, CA 95148
(408) 223-0580
Related to:
Rosbe C David, 70Savannah U Kochinke, 31Joseph O'ConnellRuss ParaynoAndrei Parayno, 34
Connected to:
Sebastian Kochinke, 31Mark A Kochinski, 63Yehonatan Kochinski, 43Danny E Kochis, 48Melissa M Kochis, 45Patricia R Kochis, 77Peter P Kochis, 42Ricky Kochis, 55Robyn F Kochis, 37Teresa Kochis, 46

Frank Kochinke Phones & Addresses

  • 3413 Antonacci Ct, San Jose, CA 95148 (408) 223-0580 (408) 644-6180
  • Santa Rosa, CA
  • Mountain View, CA
  • Fremont, CA
  • 3413 Antonacci Ct, San Jose, CA 95148 (408) 223-0580

Work

Company: Nuvora Oct 2006 Position: Vp of scientific affairs, founder

Education

Degree: PhD School / High School: Technische Universität Berlin 1987 Specialities: Chemical Engineering

Skills

Start Ups • R&D • Drug Development • Biotechnology • Pharmaceutical Industry • Medical Devices • Drug Delivery • Entrepreneurship • Technology Transfer • Leadership • Pharmaceutics • Life Sciences • Lifesciences • Gmp • Clinical Development • Commercialization • Clinical Trials • Biopharmaceuticals • Immunology • Pharmacology • Venture Capital • Clinical Research • Science • Drug Discovery • Fda • Glp • Protein Chemistry • Patents

Languages

English • German

Industries

Pharmaceuticals

Resumes

Resumes

Frank Kochinke Photo 1

Chief Executive Officer

View page
Location:
San Francisco, CA
Industry:
Pharmaceuticals
Work:
Nuvora since Oct 2006
VP of Scientific Affairs, Founder
EPS (Sole Proprietorship) Mar 1993 - 2008
President
Talima Pharmaceuticals Apr 2005 - Oct 2006
Founder, CSO
Oraviron 1998 - 2005
Founder, CSO
Oculex Pharmaceuticals 1993 - 1996
VP of R&D
Education:
Technische Universität Berlin 1987
PhD, Chemical Engineering Freie Universität Berlin 1984
MS, Physics FKS 1975
BS, Physics, Mathematics
Skills:
Start Ups
R&D
Drug Development
Biotechnology
Pharmaceutical Industry
Medical Devices
Drug Delivery
Entrepreneurship
Technology Transfer
Leadership
Pharmaceutics
Life Sciences
Lifesciences
Gmp
Clinical Development
Commercialization
Clinical Trials
Biopharmaceuticals
Immunology
Pharmacology
Venture Capital
Clinical Research
Science
Drug Discovery
Fda
Glp
Protein Chemistry
Patents
Languages:
English
German

Business Records

Name / Title
Company / Classification
Phones & Addresses
Frank Kochinke
Officer
Entrepreneurial Solution
Management Consulting Services
3413 Antonacci Ct, San Jose, CA 95148

Publications

Us Patents

Formulation For Controlled Release Of Drugs By Combining Hyrophilic And Hydrophobic Agents

View page
US Patent:
7048946, May 23, 2006
Filed:
Sep 24, 1998
Appl. No.:
09/160635
Inventors:
Vernon Wong - Rockville MD, US
Frank Kochinke - San Jose CA, US
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61K 9/10
A61K 9/14
A61K 9/06
A61K 9/70
A61K 47/38
US Classification:
424486, 424488, 424499, 424501, 424426, 424443
Abstract:
Combinations of hydrophilic and hydrophobic entities in a biodegradable sustained release implant are shown to modulate each other's rate of release. Formulations of a therapeutically active agent and modulator provide controlled, sustained release for an extended period of time.

Methods And Drug Delivery Systems For The Treatment Of Orofacial Diseases

View page
US Patent:
7074426, Jul 11, 2006
Filed:
Mar 27, 2002
Appl. No.:
10/113730
Inventors:
Frank Kochinke - San Jose CA, US
International Classification:
A61F 13/02
US Classification:
424435
Abstract:
This invention relates to methods of treating various orofacial diseases involving inflammation, infection and/or pain, using intratissue controlled release drug delivery systems. More particularly, the invention relates to methods for localized or targeted administration of a sustained release formulation of an agent such as an anti-inflammatory agent to a specified tissue location within the orofacial environment.

Compositions And Methods For Treating Conditions Of The Nail Unit

View page
US Patent:
8354095, Jan 15, 2013
Filed:
Feb 11, 2008
Appl. No.:
12/029349
Inventors:
Frank M. Kochinke - San Jose CA, US
Corinne Bright - Los Gatos CA, US
Assignee:
Hallux, Inc. - Santa Ana CA
International Classification:
A61K 8/00
A61K 31/497
US Classification:
424 61, 514 28, 514159, 51425307, 514459
Abstract:
The biodegradable drug delivery systems described here are formulated for implantation into the nail unit and its surrounding tissues for the treatment of various nail unit conditions. The systems include greater than 30% by weight of the active agent, and may be formulated as solutions, solids, semisolids, microparticles, or crystals. Methods related to the implantation and use of the biodegradable drug delivery systems for treating nail unit conditions are also described.

Compositions And Methods For Treating Conditions Of The Nail Unit

View page
US Patent:
8591870, Nov 26, 2013
Filed:
Jan 6, 2011
Appl. No.:
12/985996
Inventors:
Frank Kochinke - San Jose CA, US
Corinne Bright - Los Gatos CA, US
Assignee:
Hallux, Inc. - Laguna Hills CA
International Classification:
A61F 2/00
A61K 9/14
US Classification:
424 61, 424443, 424471, 424485
Abstract:
The biodegradable drug delivery systems described here are formulated for implantation into the nail unit and its surrounding tissues for the treatment of various nail unit conditions. The systems include non-temperature dependent phase change compositions that may be formulated as solutions, solids, semisolids, microparticles, or crystals.

Aliginate Particle Formulation

View page
US Patent:
20020051821, May 2, 2002
Filed:
Sep 7, 2001
Appl. No.:
09/949392
Inventors:
Sung-Yun Kwon - Fremont CA, US
Frank Kochinke - Fremont CA, US
International Classification:
A61K039/00
A61K039/38
A61K009/14
US Classification:
424/489000, 424/184100
Abstract:
Gelled alginate particles suitable for administration by needleless injection are loaded with a pharmacologically active agent and have a mean mass aerodynamic diameter of from 0.1 to 250 m and an envelope density of from 0.1 to 2.5 g/cm.

Formulation For Controlled Release Of Drugs By Combining Hydrophilic And Hydrophobic Agents

View page
US Patent:
20030095995, May 22, 2003
Filed:
Dec 20, 2002
Appl. No.:
10/327018
Inventors:
Vernon Wong - Rockville MD, US
Frank Kochinke - San Jose CA, US
International Classification:
A61K009/00
US Classification:
424/426000
Abstract:
Combinations of hydrophilic and hydrophobic entities in a biodegradable sustained release implant are shown to modulate each other's rate of release. Formulations of a therapeutically active agent and modulator provide substantially constant rate of release for an extended period of time.

Formulation For Controlled Release Of Drugs By Combining Hydrophilic And Hydrophobic Agents

View page
US Patent:
20050048098, Mar 3, 2005
Filed:
Sep 2, 2004
Appl. No.:
10/933971
Inventors:
Vernon Wong - Menlo Park CA, US
Frank Kochinke - San Jose CA, US
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61K031/716
A61K031/56
US Classification:
424426000, 514057000, 514171000
Abstract:
Combinations of hydrophilic and hydrophobic entities in a biodegradable sustained release implant are shown to modulate each other's rate of release. Formulations of a therapeutically active agent and modulator provide substantially constant rate of release for an extended period of time.

Formulation For Controlled Release Of Drugs By Combining Hydrophilic And Hydrophobic Agents

View page
US Patent:
20050191334, Sep 1, 2005
Filed:
Apr 29, 2005
Appl. No.:
11/117778
Inventors:
Vernon Wong - Menlo Park CA, US
Frank Kochinke - San Jose CA, US
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61F002/00
US Classification:
424426000
Abstract:
Combinations of hydrophilic and hydrophobic entities in a biodegradable sustained release implant are shown to modulate each other's rate of release. Formulations of a therapeutically active agent and modulator provide substantially constant rate of release for an extended period of time.
Control profile
Frank M Kochinke from San Jose, CA, age ~68 Get Report